Status:
RECRUITING
The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
Lead Sponsor:
West China Hospital
Conditions:
Kidney Transplant; Complications
Renal Failure Chronic
Eligibility:
All Genders
18-65 years
Brief Summary
The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This ad...
Eligibility Criteria
Inclusion
- living-donor kidney transplant recipients
- receiving standard triad immunosuppressive regimen
Exclusion
- active infection
- multi-organ transplantation
- malignancy history in the donor and recipient
- human immunodeficiency virus infection
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06577805
Start Date
July 1 2020
End Date
December 1 2025
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital, Sichuan University
Chengdu, Sichuan, China, 610041